Clinical trial
Dose-Response of Adenosine for Perioperative Pain
NCT00298636 · Xsira Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00298636 |
|---|---|
| Title | Dose-Response of Adenosine for Perioperative Pain |
| Official title | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Escalating Dose-Response Trial of Intravenous Adenosine for Perioperative Analgesia in Females Undergoing Abdominal Hysterectomy or Myomectomy |
| Lead sponsor | Xsira Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Perioperative Pain |
| Intervention type | Drug |
| Interventions | adenosine |
| Enrollment | 160 |
| Start date | Oct 1, 2005 |
| First posted | Mar 2, 2006 |
| Last update posted | Aug 2, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: